The invention relates to the use of a monoamine neurotransmitter re-uptake
inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a
pharmaceutically acceptable salt, solvate, or physiologically functional
derivative thereof for a medicament for the for the sustained reduction
of body weight.